Previous studies have illustrated that CAV-1 may be involved at the earlies stages of atherosclerosis development through increased LDL particle transcytosis, endothelial cells activation, and induced protherogenic molecule CD36 and vascular cell adhesion molecule-1 expression [12,38–39]. This evidence concerns the gene CAV1 and atherosclerosis.